Biosimilar Market Projected to Reach USD 102.29 Billion by 2032, Driven by Patent Expirations and Demand for Cost-Effective Biologic Therapies
The global biosimilar market, valued at USD 29.09 billion in 2024, is anticipated to grow at a compound annual growth rate (CAGR) of 17.02%, reaching approximately USD 102.29 billion by 2032. This growth is propelled by the expiration of...
English
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt